EMBREX INC/NC
10-Q, EX-27, 2000-08-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: EMBREX INC/NC, 10-Q, 2000-08-10
Next: MANOR CARE INC, 10-Q, 2000-08-10



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           1,913
<SECURITIES>                                         0
<RECEIVABLES>                                    5,021
<ALLOWANCES>                                         0
<INVENTORY>                                      2,145
<CURRENT-ASSETS>                                 1,646
<PP&E>                                          39,036
<DEPRECIATION>                                (24,563)
<TOTAL-ASSETS>                                  25,198
<CURRENT-LIABILITIES>                            4,860
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            86
<OTHER-SE>                                      20,231
<TOTAL-LIABILITY-AND-EQUITY>                    25,198
<SALES>                                          9,674
<TOTAL-REVENUES>                                 9,674
<CGS>                                          (4,160)
<TOTAL-COSTS>                                  (4,160)
<OTHER-EXPENSES>                               (3,408)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                (16)
<INCOME-PRETAX>                                  2,137
<INCOME-TAX>                                       220
<INCOME-CONTINUING>                              1,917
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,917
<EPS-BASIC>                                       0.24
<EPS-DILUTED>                                     0.22


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission